Pharmacologic management of attention deficit hyperactivity disorder in children and adolescents: a review for practitioners

被引：42
作者：
Brown, Kelly A. [1 ]
Samuel, Sharmeen [1 ]
Patel, Dilip R. [1 ]
机构：
[1] Western Michigan Univ, Homer Stryker MD Sch Med, Dept Pediat & Adolescent Med, 1000 Oakland Dr, Kalamazoo, MI 49008 USA
来源：
TRANSLATIONAL PEDIATRICS | 2018年 / 7卷 / 01期
关键词：
Attention-deficit/hyperactivity disorder (ADHD); stimulants; non-stimulant medication; methylphenidate; amphetamine; alpha-2-agonists; DEFICIT/HYPERACTIVITY DISORDER; CARDIOVASCULAR EVENTS; STIMULANT-DRUGS; UNITED-STATES; ADHD DRUGS; ATOMOXETINE; METHYLPHENIDATE; SAFETY; PHARMACOTHERAPY; RELEASE;
D O I：
10.21037/tp.2017.08.02
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Attention-deficit/hyperactivity disorder (ADHD) is a common neurobehavioral disorder in children and adolescents. ADHD affects multiple aspects of an individual's life and functioning in family, social, and academic realms. Effective management of ADHD is necessary for children and adolescents and may include non-pharmacologic treatments, pharmacologic therapy including use of stimulant and non-stimulant medications, or a combination of the different treatment modalities. In general, medications used to treat ADHD are safe and effective. Medical practitioners can follow a step-wise approach in the selection and adjustment of pharmacologic agents to treat ADHD, while working closely with families, caregivers, and other medical and educational professionals to form appropriate treatment plans. This article reviews practical aspects of pharmacological treatment of ADHD in children and adolescents.
引用
收藏
页码：36 / 47
页数：12
相关论文
共 38 条
  • [1] [Anonymous], 2013, Diagnostic and statistical manual of mental disorders, V5th, P59, DOI DOI 10.1176/APPI.BOOKS.9780890425596
  • [2] [Anonymous], 2016, CAR CHILDR ADHD RES
  • [3] Meta-Analysis of Suicide-Related Behavior or Ideation in Child, Adolescent, and Adult Patients Treated with Atomoxetine
    Bangs, Mark E.
    Wietecha, Linda A.
    Wang, Shufang
    Buchanan, Andrew S.
    Kelsey, Douglas K.
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2014, 24 (08) : 426 - 434
  • [4] Sudden cardiac death in children and adolescents: introduction and overview
    Berger, S
    Kugler, JD
    Thomas, JA
    Friedberg, DZ
    [J]. PEDIATRIC CLINICS OF NORTH AMERICA, 2004, 51 (05) : 1201 - +
  • [5] Briars Leslie, 2016, J Pediatr Pharmacol Ther, V21, P192, DOI 10.5863/1551-6776-21.3.192
  • [6] Charach A, ATTENTION DEFICIT HY
  • [7] Charach A, 2011, AHRQ, V44
  • [8] ADHD Drugs and Serious Cardiovascular Events in Children and Young Adults
    Cooper, William O.
    Habel, Laurel A.
    Sox, Colin M.
    Chan, K. Arnold
    Arbogast, Patrick G.
    Cheetham, T. Craig
    Murray, Katherine T.
    Quinn, Virginia P.
    Stein, C. Michael
    Callahan, S. Todd
    Fireman, Bruce H.
    Fish, Frank A.
    Kirshner, Howard S.
    O'Duffy, Anne
    Connell, Frederick A.
    Ray, Wayne A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (20) : 1896 - 1904
  • [9] Cardiovascular Safety of Stimulants in Children with Attention-Deficit/Hyperactivity Disorder: A Nationwide Prospective Cohort Study
    Dalsgaard, Soren
    Kvist, Anette Primdal
    Leckman, James F.
    Nielsen, Helena Skyt
    Simonsen, Marianne
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2014, 24 (06) : 302 - 310
  • [10] Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children
    Findling, RL
    Biederman, J
    Wilens, TE
    Spencer, TJ
    McGough, JJ
    Lopez, FA
    Tulloch, SJ
    [J]. JOURNAL OF PEDIATRICS, 2005, 147 (03) : 348 - 354
1234